Published in Lab Invest on December 01, 1995
Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology (2001) 2.37
Standardization and definitions in lower urinary tract dysfunction in children. International Children's Continence Society. Br J Urol (1998) 2.28
Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology (1986) 1.80
Increased plasma methylmalonic acid level does not predict clinical manifestations of vitamin B12 deficiency. Arch Intern Med (2001) 1.63
Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg (1992) 1.59
Sleep deprivation induces excess diuresis and natriuresis in healthy children. Am J Physiol Renal Physiol (2011) 1.53
Immunohistochemical localization of epidermal growth factor in rat and man. Histochemistry (1986) 1.53
Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol (1989) 1.52
Age related nocturnal urine volume and maximum voided volume in healthy children: reappraisal of International Children's Continence Society definitions. J Urol (2010) 1.47
Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I. Diabetes (1996) 1.44
Continuous direct tissue oxygen tension measurement. A new application for an intravascular oxygen sensor. Ann Chir Gynaecol (1991) 1.40
[Homocysteine and cardiovascular disease]. Ugeskr Laeger (2001) 1.39
Role of submandibular saliva and epidermal growth factor in gastric cytoprotection. Gastroenterology (1984) 1.38
[Urinary incontinence--not the same we are talking about]. Ugeskr Laeger (1998) 1.38
[Diagnosis and vitamin B12 deficiency]. Tidsskr Nor Laegeforen (2001) 1.38
Detection of epidermal growth factor-urogastrone and its receptor during fetal mouse development. Proc Natl Acad Sci U S A (1980) 1.35
Diurnal anti-diuretic-hormone levels in enuretics. J Urol (1985) 1.35
Standardization of outcome studies in patients with lower urinary tract dysfunction: a report on general principles from the Standardisation Committee of the International Continence Society. Neurourol Urodyn (1998) 1.34
Nocturnal enuresis: an approach to treatment based on pathogenesis. J Pediatr (1989) 1.29
Colorectal function in patients with spinal cord lesions. Dis Colon Rectum (1997) 1.23
Effect of sialoadenectomy and synthetic human urogastrone on healing of chronic gastric ulcers in rats. Gut (1986) 1.23
Effect of the cobalt-N coordination on the cobamide recognition by the human vitamin B12 binding proteins intrinsic factor, transcobalamin and haptocorrin. Eur J Biochem (1991) 1.22
Gut-homing CD4+ T cell receptor alpha beta+ T cells in the pathogenesis of murine inflammatory bowel disease. Eur J Immunol (1994) 1.21
Molecular dissection of the intrinsic factor-vitamin B12 receptor, cubilin, discloses regions important for membrane association and ligand binding. J Biol Chem (1999) 1.21
Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur J Clin Invest (2002) 1.20
Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis. Proc Natl Acad Sci U S A (1996) 1.17
A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients. Cancer Res (2001) 1.15
Isolation of the human placenta receptor for epidermal growth factor-urogastrone. Nature (1979) 1.15
Epidermal growth factor inhibits cysteamine-induced duodenal ulcers. Gastroenterology (1983) 1.15
Pancreatic and intestinal processing of proglucagon in man. Diabetologia (1987) 1.13
Downregulation of AQP1, -2, and -3 after ureteral obstruction is associated with a long-term urine-concentrating defect. Am J Physiol Renal Physiol (2001) 1.12
Biosynthesis of intestinal microvillar proteins. Role of the Golgi complex and microtubules. Biochem J (1983) 1.11
Effects of a prostaglandin E1 derivative, SC-29333, and aspirin on gastric ionic fluxes and potential difference in dogs. J Pharmacol Exp Ther (1979) 1.08
Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut (2000) 1.08
Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology (1988) 1.07
Nocturnal polyuria and natriuresis in male patients with nocturia and lower urinary tract symptoms. J Urol (1996) 1.07
Loperamide binding to opiate receptor sites of brain and myenteric plexus. J Pharmacol Exp Ther (1976) 1.06
CD4+ T lymphocytes injected into severe combined immunodeficient (SCID) mice lead to an inflammatory and lethal bowel disease. Clin Exp Immunol (1996) 1.05
Chemistry and synthetic development of misoprostol. Dig Dis Sci (1985) 1.05
Quantitation of epidermal growth factor in the rat. Identification and partial characterization of duodenal EGF. Scand J Gastroenterol (1983) 1.05
Volume of blood removed for analytical purposes during hospitalization of low-birthweight infants. Clin Chem (1981) 1.04
SC-29333: a potent inhibitor of canin gastric secretion. Am J Dig Dis (1976) 1.04
Effects of E prostaglandins on canine gastric potential difference. Am J Dig Dis (1978) 1.03
Vasoactive intestinal polypeptidergic nerves and Brunner's gland secretion in the rat. Gastroenterology (1981) 1.03
Short-term insulin treatment prevents the diabetogenic action of streptozotocin in rats. Endocrinology (1997) 1.03
Solubilization and isolation of the human placenta receptor for epidermal growth factor-urogastrone. J Biol Chem (1980) 1.00
Immunohistochemical localisation and developmental aspects of epidermal growth factor in the rat. Histochemistry (1988) 1.00
Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice. Gut (2004) 1.00
Conditional stimulation of the dorsal penile/clitoral nerve may increase cystometric capacity in patients with spinal cord injury. Neurourol Urodyn (2003) 0.99
Oral administration of synthetic human urogastrone promotes healing of chronic duodenal ulcers in rats. Gastroenterology (1986) 0.99
Enuresis as protective factor in vesicoureteral reflux. Urology (1985) 0.98
C-reactive protein and bacterial meningitis: a meta-analysis. Scand J Clin Lab Invest (1998) 0.98
Prevalent urinary incontinence as a correlate of pregnancy, vaginal childbirth, and obstetric techniques. Am J Public Health (1999) 0.97
Short bowel patients treated for two years with glucagon-like Peptide 2: effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle function. Gastroenterol Res Pract (2009) 0.97
[Blood transfusion increases the risk of surgical infection]. Ugeskr Laeger (1993) 0.96
Health technology assessment in clinical biochemistry. Methylmalonic acid: a Danish showcase. Scand J Clin Lab Invest (2003) 0.96
Substance P and neurokinin A are codistributed and colocalized in the porcine gastrointestinal tract. Peptides (1992) 0.96
Healing of cysteamine-induced duodenal ulcers in the rat. Dig Dis Sci (1985) 0.95
Obstructive nephropathy: an update of the experimental research. Urol Res (1999) 0.95
Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal--jejunal transposition or small bowel resection. Dig Dis Sci (2001) 0.95
Cysteamine-induced duodenal ulcer and acid secretion in the rat. Scand J Gastroenterol (1980) 0.95
Immunoassays of human trefoil factors 1 and 2: measured on serum from patients with inflammatory bowel disease. Scand J Clin Lab Invest (2004) 0.95
Determining the displacement of the pelvic floor and pelvic organs during voluntary contractions using magnetic resonance imaging in younger and older women. BJU Int (2002) 0.94
Vitamin B-12 treatment has limited effect on health-related quality of life among individuals with elevated plasma methylmalonic acid: a randomized placebo-controlled study. J Intern Med (2003) 0.94
Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis. Br J Cancer (1998) 0.94
The incidence of granulomas in serial sections of rectal biopsies from patients with Crohn's disease. Acta Pathol Microbiol Immunol Scand A (1982) 0.94
Effect of vasoactive intestinal polypeptide and somatostatin on secretion of epidermal growth factor and bicarbonate from Brunner's glands. Gut (1984) 0.94
Experimental partial unilateral ureter obstruction. I. Pressure flow relationship in a rat model with mild and severe acute ureter obstruction. J Urol (1998) 0.93
Acute effects of smoking during modified sham feeding in duodenal ulcer patients. An analysis of nicotine, acid secretion, gastrin, catecholamines, epidermal growth factor, prostaglandin E2, and bile acids. Scand J Gastroenterol (1993) 0.93
Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon. Scand J Gastroenterol (2002) 0.93
Renal origin of rat urinary epidermal growth factor. Regul Pept (1984) 0.93
Impedance planimetry: a new approach to biomechanical intestinal wall properties. Dig Dis (1991) 0.93
Intraosseous phlebography, intraosseous pressure measurements and 99mTC-polyphosphate scintigraphy in patients with various painful conditions in the hip and knee. Acta Orthop Scand (1980) 0.93
Expression of the epidermal growth factor system in human endometrium during the menstrual cycle. Mol Hum Reprod (2005) 0.92
Conformational changes of transcobalamin induced by aquocobalamin binding. Mechanism of substitution of the cobalt-coordinated group in the bound ligand. J Biol Chem (2000) 0.92
The pathophysiology of enuresis in children and young adults. Clin Pediatr (Phila) (1993) 0.92
Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice. Endocrinology (2000) 0.91
Holotranscobalamin - a sensitive marker of cobalamin malabsorption. Eur J Clin Invest (1999) 0.91
Experience and current status of research into the pathophysiology of nocturnal enuresis. Br J Urol (1997) 0.91
No relationship between subjective assessment of urinary incontinence and pad test weight gain in a random population sample of menopausal women. J Urol (1998) 0.91
Distribution and metabolism of intravenously administered trefoil factor 2/porcine spasmolytic polypeptide in the rat. Gut (1998) 0.90
Short- and long-term reproducibility of cystometry. Urol Res (1989) 0.90
Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines. Anticancer Res (2000) 0.90
Biomechanical wall properties of the human rectum. A study with impedance planimetry. Gut (1993) 0.90
Nocturnal polyuria in monosymptomatic nocturnal enuresis refractory to desmopressin treatment. Am J Physiol Renal Physiol (2006) 0.90
Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life. Gastroenterol Res Pract (2009) 0.90
Characterization of the particulate and soluble acceptor for transcobalamin II from human placenta and rabbit liver. Biochim Biophys Acta (1980) 0.89
Single dose imipramine reduces nocturnal urine output in patients with nocturnal enuresis and nocturnal polyuria. J Urol (1997) 0.89
The effect of cysteamine on the Brunner gland secretion in the rat. Scand J Gastroenterol (1981) 0.89
The four-electrode impedance technique: a method for investigation of compliance in luminal organs. Clin Phys Physiol Meas (1988) 0.89